STOCK TITAN
  1. Home
  2. News
  3. SSII

SS INNOVATIONS INTL INC - $SSII STOCK NEWS

Welcome to our dedicated page for SS INNOVATIONS INTL news (Ticker: $SSII), a resource for investors and traders seeking the latest updates and insights on SS INNOVATIONS INTL stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SS INNOVATIONS INTL's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SS INNOVATIONS INTL's position in the market.

News
SS Innovations Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System
Rhea-AI Summary

SS Innovations International, Inc. (SSII) achieved a significant milestone by successfully performing the first infant pyeloplasty using its flagship SSi Mantra Surgical Robotic System. The procedure, led by Dr. Chandra Mohan Vaddi in Hyderabad, India, was a success on a 12-month-old baby. The SSi Mantra is the first surgical system made in India and is cost-effective with regulatory approval in India, Guatemala, and Indonesia. The system has been used in over 1000 surgical procedures across various specialties. SS Innovations is seeking regulatory approval in the US and EU by late 2024 or 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
SS Innovations International Announces Q1 2024 Company Updates
Rhea-AI Summary
SS Innovations International, Inc. (OTC: SSII) announced its Q1 2024 updates, highlighting the successful installations of the SSi Mantra Surgical Robotic System in India, launching cardiac surgery programs, selling 8 robotic systems with expected revenues of US $7 million, and achieving a milestone of 1,000 surgeries. Dr. Sudhir Srivastava also mentioned the training program at the World Laparoscopy Hospital, aiming to increase global adoption of their innovative robotic system.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.91%
Tags
earnings
-
News
SS Innovations’ Flagship SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures
Rhea-AI Summary
SS Innovations International, Inc. (SSII) successfully conducts first-ever telesurgery using SSi Mantra Surgical Robotic System on an animal in India. The surgery involved four complex procedures and was led by world-class surgeons. The Company aims to revolutionize healthcare by making telesurgery accessible globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.5%
Tags
none
News
SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement
Rhea-AI Summary
SS Innovations International, Inc. announces the successful performance of the world's first mitral valve replacement using the Made in India SSi Mantra Surgical Robotic System at the Narayana Institute of Cardiac Sciences. Dr. Nitin Kumar Rajput led the surgery, marking a significant milestone in cardiac care. The SSi Mantra system aims to offer minimally invasive solutions for cardiac patients, with regulatory approval in multiple countries and a growing market size. SS Innovations plans to expand regulatory approvals to the US and EU by 2024 or 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-24.71%
Tags
none
-
News
SS Innovations Demonstrates Groundbreaking Telesurgery Platform at Company’s First Multi-Specialty Robotic Surgical Conference
Rhea-AI Summary
SS Innovations International, Inc. conducted a groundbreaking live telesurgery demonstration at the inaugural SS Innovations Multi-Specialty Robotic Surgical Conference, showcasing their flagship robotic surgical system, the SSi Mantra™. The remote telesurgery demonstration included precisely suturing on a coronary artery less than one millimeter in diameter on a porcine heart model. The SSi Mantra™ Surgical Robotic System is the first surgical system to be made in India and has been granted regulatory approval in India and Guatemala, with more than 650 surgical procedures performed using the system to date.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
SS Innovations Announces Filing of Pre-Submission Application to the Center for Devices and Radiological Health (CDRH) of the United States Food and Drug Administration
Rhea-AI Summary
SS Innovations International, Inc. (SSII) has filed a pre-submission application with the FDA for its SSi Mantra™ Surgical Robotic System, receiving acknowledgment from the CDRH. The company is working towards obtaining approvals in the United States and Europe, having already obtained regulatory approval in India and Guatemala. The SSi Mantra™ is the first surgical system made in India and is cost-effective with broad-spectrum surgical applications, including cardiac surgery.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.98%
Tags
none
News
SS Innovations Partners with India’s Leading Medical Equipment Supplier, Medikabazaar
Rhea-AI Summary
SS Innovations International, Inc. (SSII) has partnered with Medikabazaar, a leading medical equipment supplier in India, to facilitate sales of its flagship SSi Mantra Surgical Robotic System to hospitals and medical facilities across India. The partnership aims to make robotic surgery affordable and accessible to a global population, with the SSi Mantra Surgical Robotic System being the first surgical system made in India, granted regulatory approval in India and Guatemala, and clinically validated in more than 40 different types of surgical procedures. The system is cost-effective with broad-spectrum surgical applications, including cardiac surgery, and has already been used in over 650 surgical procedures. SS Innovations is also seeking regulatory approvals in the United States and Europe, expected to be received in 2024 and 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.51%
Tags
partnership
-
News
SS Innovations Launches Groundbreaking Inaugural Multi-Specialty Robotic Surgical Conference
Rhea-AI Summary
SS Innovations International, Inc. hosted the inaugural SS Innovations Multi-Specialty Robotic Surgical Conference (SMRSC) in India, showcasing the SSi Mantra Surgical Robotic System. The event featured 13 live surgeries, panel discussions, and scientific sessions, with a focus on the integration of Artificial Intelligence in surgery and the pursuit of sustainable tele-surgery. The SSi Mantra is the first surgical robotic system made in India, with regulatory approval and clinical validation in over 40 different surgical procedures. The company is seeking regulatory approvals in the United States and Europe in 2024 and 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.33%
Tags
none
-
News
SS Innovations Achieves Significant Milestones in 2023
Rhea-AI Summary
SS Innovations International, Inc. (OTC: SSII) has achieved significant milestones in 2023, including completing over 550 surgeries with the SSi Mantra surgical robotic system, receiving regulatory approvals in multiple countries, and entering into strategic partnerships and distribution agreements. The company is working towards securing regulatory approvals in the United States and Europe, with a focus on making robotic surgery accessible and affordable globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.9%
Tags
none
News
SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa
Rhea-AI Summary
SS Innovations International, Inc. (SSII) has entered a strategic partnership with Surgical Lab, Ltd., a Cairo-based medical device distributor, to provide accessibility to the SSi Mantra Surgical Robotic System for the entire African continent. Surgical Lab has begun registration of SSi Mantra in 27 African countries, marking a significant milestone for SS Innovations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.45%
Tags
partnership
Stock SSII logo
SS INNOVATIONS INTL INC

OTC:SSII

SSII Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

SSII Stock Data

1.02B
33.27M
80.45%
Small Arms, Ordnance, and Ordnance Accessories Manufacturing
Manufacturing
Link
United States of America
Orlando

About SSII

avra was organized by a senior leadership team with broad and deep experience in medical research, innovation, and development in the medical robotics field. the company plans to exploit the growing demand for practical medical robotic devices by developing a platform—independent precision guidance system with an initial focus on skin resurfacing.